Dental caries occur when the acid from plaque erodes the tooth enamel
and forms cavities. Caries is a common dental disease, prevalent in
both developed and developing countries, affecting every stratum and age
group of the society. The FISABIO Foundation discovered a new bacterial
species named Streptococcus dentisani, which acts as a shield against
caries-causing bacteria, producing a substance that inhibits them and
prevents caries. Streptococcus dentisani bacteria is used as a
preventive probiotic product to improve oral health in the food and
cosmetic industries (mouthwash, toothpaste). Probiotic solutions are
expected to be a groundbreaking approach toward anticaries treatment as
these solutions have the potential to improve health and reduce health
care expenditure. Anticaries treatment is considered an attractive
concept for next-generation anticavity therapy, as it has the potential
to prevent tooth replacement or other dental surgical replacements
required due to cavity formation. The use and availability of different
types of anticaries treatments have evolved over the past century;
however, further research is ongoing in order to develop its more
clinical applications and reduce the adverse effects associated with the
use of anticaries treatments.
A major factor driving the anticaries treatments market is the high
incidence of dental problems globally. Rise in incidence of periodontics
among young adults and increase in demand for stem cell anticaries
treatment techniques, especially among the geriatric population, are the
other factors anticipated to drive the anticaries treatments market
during the forecast period. Favorable price of anticaries products and
emergence of new technologies using an anticaries product as a
functional food, mouthwash, toothpaste, chewing gum, etc. are expected
to propel the global anticaries treatments market. According to the
World Health Organization, complete loss of teeth affects approximately
30% of the geriatric population in the age group of 65-74 years.
However, prevalence rates of anticaries are increasing in low and middle
income countries. Factors, such as, preference for endodontic treatment
over anticaries treatment in major dental surgeries and local
inflammatory activity which results in chronic complications and dental
replacements are projected to restrain the growth of the anticaries
treatments market during the forecast period.
The global anticaries treatments market can be segmented on the basis
of product type, end-user, and region. In terms of product type, the
anticaries treatments market can be categorized into topical solution,
gel-based, foam-based, toothpaste, and others. The gel-based segment
accounted for a prominent share of the global anticaries treatments
market in 2017, due to increasing prevalence of dental surgery and
rising demand for cosmetic surgery, especially in the emerging
economies, such as, China, Brazil, and India. In terms of end-user, the
anticaries treatments market can be divided into cosmetic industry, home
care, dental clinics, and others.
In terms of region, the global anticaries treatments market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global anticaries treatments market during the forecast period due to increasing dental services and stem cell research in the region. According to the Dental Health Services, in 2015, total expenditure on dental services in Canada amounted to US$ 13.6 Bn. Expenditure of the private sector was estimated at US$ 12.7 Bn, while that of the public sector at US$ 846 Mn. In April 2017, Unilever launched an in-clinic remineralisation regime to regenerate professionally advanced enamel serum. The Unilever brand claimed 82% of the enamel mineral regenerated after 3 days. Furthermore, increasing prevalence of dental cavities and periodontics, especially in the developing countries, such as, China and India has boosted the demand for dental surgery. According to the World Health Organization, nearly 60% to 90% of school children and nearly 100% of adults have dental cavities. The incidence of dental surgery, general prosthetic fixation, periodontal inflammation, and other dental diseases is increasing in Asia Pacific. This, in turn, is anticipated to fuel the demand for cost-effective aesthetic and dental surgeries. These factors are projected to drive the anticaries treatments market in Asia Pacific between 2018 and 2026.
Key players operating in the global anticaries treatments market include Unilever, Ocata Therapeutics, ICPA Health, GlaxoSmithKline plc, and Church & Dwight, Inc.
In terms of region, the global anticaries treatments market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global anticaries treatments market during the forecast period due to increasing dental services and stem cell research in the region. According to the Dental Health Services, in 2015, total expenditure on dental services in Canada amounted to US$ 13.6 Bn. Expenditure of the private sector was estimated at US$ 12.7 Bn, while that of the public sector at US$ 846 Mn. In April 2017, Unilever launched an in-clinic remineralisation regime to regenerate professionally advanced enamel serum. The Unilever brand claimed 82% of the enamel mineral regenerated after 3 days. Furthermore, increasing prevalence of dental cavities and periodontics, especially in the developing countries, such as, China and India has boosted the demand for dental surgery. According to the World Health Organization, nearly 60% to 90% of school children and nearly 100% of adults have dental cavities. The incidence of dental surgery, general prosthetic fixation, periodontal inflammation, and other dental diseases is increasing in Asia Pacific. This, in turn, is anticipated to fuel the demand for cost-effective aesthetic and dental surgeries. These factors are projected to drive the anticaries treatments market in Asia Pacific between 2018 and 2026.
Key players operating in the global anticaries treatments market include Unilever, Ocata Therapeutics, ICPA Health, GlaxoSmithKline plc, and Church & Dwight, Inc.
No comments:
Post a Comment